Amgen Correlations

AMGN Stock  USD 265.86  6.19  2.28%   
The current 90-days correlation between Amgen Inc and Merck Company is 0.76 (i.e., Poor diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Amgen Correlation With Market

Very weak diversification

The correlation between Amgen Inc and DJI is 0.5 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Moving together with Amgen Stock

  0.78JNJ Johnson JohnsonPairCorr
  0.93MRK Merck CompanyPairCorr
  0.81PFE Pfizer IncPairCorr
  0.69GSD Devonian Health GroupPairCorr
  0.67MMM 3M CompanyPairCorr
  0.64AA Alcoa CorpPairCorr

Moving against Amgen Stock

  0.69WHLRD Wheeler Real EstatePairCorr
  0.55AVCR Avricore HealthPairCorr
  0.54PCRX Pacira BioSciences,PairCorr
  0.53ANIP ANI PharmaceuticalsPairCorr
  0.52RGC Regencell Bioscience TrendingPairCorr
  0.47CWT California Water ServicePairCorr
  0.64PMHG Prime Meridian HoldingPairCorr
  0.41WMT WalmartPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Amgen Stock performing well and Amgen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Amgen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Amgen Corporate Management

Jonathan JDGeneral VPProfile
Linda LouieVP OfficerProfile
James MDExecutive DevelopmentProfile
Nancy GrygielSenior OfficerProfile